Adhera Therapeutics Selects IQVIA’s OCE Technology Platform

IQVIA announced Adhera Therapeutics has selected Orchestrated Customer Engagement (OCE) to build its commercial infrastructure and bring the company’s specialty drug innovations to patients.

OCE accelerates a transformation in commercial engagement for life sciences companies by connecting functions, data, insights, and activities horizontally to break down silos and provide a holistic view of the customer. This gives the company and its clients, a streamlined customer experience. Adhera Therapeutics will leverage the OCE technology platform to deliver more intelligent and actionable insight to its commercial teams.

“We have confidence that IQVIA’s OCE platform will support our mission to develop and commercialize unique pharmaceutical therapies and leverage technology to improve patient outcomes,” said Robert C. Moscato, Jr., chief executive officer of Adhera Therapeutics. “We wanted to provide our sales team and home office users with the leading technology to support our current business needs but also have a customer relationship management solution that will support our future needs as we grow.”

The platform will allow Adhera to start from scratch as it builds and strengthens a true commercial infrastructure over time.

“We are pleased that Adhera will be implementing our OCE technology platform,” said Tal Rosenberg, senior vice president, Global Technology Solutions at IQVIA. “IQVIA has a proven portfolio of innovative technology solutions including CRM specifically designed for life sciences. Adhera understands that the value of our new OCE platform is its ability to capitalize on this deep industry knowledge. In short, OCE helps companies improve their customer engagement model by creating a better user experience, connecting all commercial team members, and efficiently delivering tailored insight to each unique commercial team member.”

  • <<
  • >>